136 related articles for article (PubMed ID: 10951840)
1. [Guidelines for cardioverter defibrillator implantation].
Andrade JC; Avila Neto V; Braile DM; Brofman PR; Costa AR; Costa R; Galvão Filho SS; Gauch PR; Lucchese FA; Martinelli Filho M; Medeiros PT; Mateos JC; Pimenta J; Takeda RT
Arq Bras Cardiol; 2000 May; 74(5):481-2. PubMed ID: 10951840
[No Abstract] [Full Text] [Related]
2. [Complication after implantable cardioverter defibrillator implantation: report of 1 case].
Lou ZY; Zhou MH; Li XQ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):360. PubMed ID: 15803642
[No Abstract] [Full Text] [Related]
3. [Use of implantable cardioverter defibrillators in the secondary prevention of malignant ventricular arrhythmias: lessons from large studies].
Anadolu Kardiyol Derg; 2001 Mar; 1(1):43-7, AXIV. PubMed ID: 12132492
[TBL] [Abstract][Full Text] [Related]
4. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
Della Bella P
Ital Heart J Suppl; 2000 Aug; 1(8):1070-1. PubMed ID: 10993020
[No Abstract] [Full Text] [Related]
5. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
Proclemer A; Ghidina M
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
[No Abstract] [Full Text] [Related]
6. Chapter 10. Current evidence on the cost effectiveness of the implantable cardioverter defibrillator.
O'Brien BJ; Yee R
Can J Cardiol; 2000 Jun; 16 Suppl C():45C-7C. PubMed ID: 10887279
[No Abstract] [Full Text] [Related]
7. Food for afterthought: reflections from 2 implantable cardioverter defibrillator trials.
Rahimtoola SH
Arch Intern Med; 2004 Sep; 164(17):1835-9. PubMed ID: 15451756
[No Abstract] [Full Text] [Related]
8. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
Sinha SK; Mehta D; Gomes JA
Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255
[TBL] [Abstract][Full Text] [Related]
9. Can incremental innovation of implantable cardioverter-defibrillator systems become disruptive to patient care? Moore's law gone awry.
Naccarelli GV
J Cardiovasc Electrophysiol; 2006 Jun; 17(6):621-2. PubMed ID: 16836710
[No Abstract] [Full Text] [Related]
10. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
Zareba W
Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515
[No Abstract] [Full Text] [Related]
11. Stabilizing and resuscitating patients with automatic implantable cardioverter-defibrillators.
Ellis JI
West J Med; 1993 Nov; 159(5):595-6. PubMed ID: 8279158
[No Abstract] [Full Text] [Related]
12. Superior vena cava syndrome and syncope in an implantable cardioverter defibrillator recipient.
Kostopoulou A; Sbarouni E; Livanis EG; Theodorakis GN; Kremastinos D
Europace; 2004 May; 6(3):205-8. PubMed ID: 15121071
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and limitations of treatment of ventricular fibrillation/ventricular tachycardia storm by subcutaneous implantable cardioverter defibrillator.
Nagra B; Awan MU; Miriyala V; Kantharia BK
Int J Cardiol; 2016 Nov; 222():978-979. PubMed ID: 27529389
[No Abstract] [Full Text] [Related]
14. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
[TBL] [Abstract][Full Text] [Related]
15. [How do we treat an electrical storm in implantable cardioverter defibrillator (ICD) appropriate patients?].
Özin B
Turk Kardiyol Dern Ars; 2014 Jun; 42(4):417. PubMed ID: 25112002
[No Abstract] [Full Text] [Related]
16. [Implantable cardioventer defibrillator in the treatment of malignant ventricular arrhythmias and its short-term follow-up].
Liu QM; Zhang Y; Zhou SH
Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):179-80. PubMed ID: 12575357
[No Abstract] [Full Text] [Related]
17. Implantable cardioverter-defibrillators.
Kutalek SP; Dreifus LS
Adv Intern Med; 1993; 38():421-38. PubMed ID: 8438649
[No Abstract] [Full Text] [Related]
18. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
[TBL] [Abstract][Full Text] [Related]
19. I have an implantable cardioverter defibrillator (ICD), and I've been taking fish oil supplements because I had heard of their potential heart benefits. However, I recently read they might not be safe for people with ICDs. Should I stop taking them?
Johns Hopkins Med Lett Health After 50; 2005 Oct; 17(8):8. PubMed ID: 16247866
[No Abstract] [Full Text] [Related]
20. Implantable cardioverter/defibrillators (ICDs).
Med Lett Drugs Ther; 1994 Sep; 36(932):86-8. PubMed ID: 8084305
[No Abstract] [Full Text] [Related]
[Next] [New Search]
